- Home
- MXCT vs QTRX Comparison
MXCT vs QTRX Comparison
Compare MXCT & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MXCT
- QTRX
- Stock Information
- Founded
- MXCT 1999
- QTRX 2007
- Country
- MXCT United States
- QTRX United States
- Employees
- MXCT N/A
- QTRX N/A
- Industry
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- MXCT Health Care
- QTRX Industrials
- Exchange
- MXCT Nasdaq
- QTRX Nasdaq
- Market Cap
- MXCT 375.0M
- QTRX 439.1M
- IPO Year
- MXCT 2021
- QTRX 2017
- Fundamental
- Price
- MXCT $4.24
- QTRX $10.50
- Analyst Decision
- MXCT Strong Buy
- QTRX Strong Buy
- Analyst Count
- MXCT 2
- QTRX 4
- Target Price
- MXCT $9.50
- QTRX $23.25
- AVG Volume (30 Days)
- MXCT 704.7K
- QTRX 375.4K
- Earning Date
- MXCT 11-06-2024
- QTRX 11-12-2024
- Dividend Yield
- MXCT N/A
- QTRX N/A
- EPS Growth
- MXCT N/A
- QTRX N/A
- EPS
- MXCT N/A
- QTRX N/A
- Revenue
- MXCT $45,599,000.00
- QTRX $129,330,000.00
- Revenue This Year
- MXCT N/A
- QTRX $13.89
- Revenue Next Year
- MXCT $21.27
- QTRX $15.51
- P/E Ratio
- MXCT N/A
- QTRX N/A
- Revenue Growth
- MXCT 19.85
- QTRX 15.52
- 52 Week Low
- MXCT $3.17
- QTRX $9.87
- 52 Week High
- MXCT $5.55
- QTRX $29.70
- Technical
- Relative Strength Index (RSI)
- MXCT 60.65
- QTRX 40.42
- Support Level
- MXCT $3.98
- QTRX $10.29
- Resistance Level
- MXCT $4.55
- QTRX $11.51
- Average True Range (ATR)
- MXCT 0.26
- QTRX 0.80
- MACD
- MXCT 0.03
- QTRX -0.13
- Stochastic Oscillator
- MXCT 70.62
- QTRX 20.10
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory, Homebrew - Custom Assay Development, and Uman NF-Light.